DSM's pharmaceutical facing business saw first quarter sales decline 5% to €197m, however profit for the business unit rose 3% to €11m. DSM attributed the sales decline to the disposal of a business unit at the end of 2008.
DSM
Tuesday 28 April 2009
DSM pharma sales decline, profit rises
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment